BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17498527)

  • 1. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA; Mamounas EP
    Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ--current management.
    O'Sullivan MJ; Morrow M
    Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative approach for breast cancer. The experience of the European Institute of Oncology].
    Gentilini O; Veronesi P; Gatti G; Intra M; Mazzarol G; Trifirò G; Bassi F; Caliskan M; Da Lima L; Galimberti V; Luini A
    Minerva Chir; 2007 Dec; 62(6):447-58. PubMed ID: 18091655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current trends in the treatment of primary breast cancer].
    Letiagin VP
    Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
    [No Abstract]   [Full Text] [Related]  

  • 6. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
    Christian MC; McCabe MS; Korn EL; Abrams JS; Kaplan RS; Friedman MA
    N Engl J Med; 1995 Nov; 333(22):1469-74. PubMed ID: 7477148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.
    Wright JR; Whelan TJ; McCready DR; O'Malley FP
    Cancer Prev Control; 1998 Dec; 2(6):312-9. PubMed ID: 10470463
    [No Abstract]   [Full Text] [Related]  

  • 10. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
    Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
    J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy for breast cancer.
    Swanson JO
    J Insur Med; 2001; 33(2):195-7. PubMed ID: 11510518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of breast cancer.
    Zurrida S; Veronesi U
    Ann Chir Gynaecol; 2000; 89(3):187-90. PubMed ID: 11079786
    [No Abstract]   [Full Text] [Related]  

  • 13. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?
    Prager D; Grundfest-Broniatowski S; Lerner HJ; Margolese RG; Dimitrov N; Silverman P
    Semin Oncol; 1995 Aug; 22(4):xiii, xix-xx, xxvi-xxvii passim. PubMed ID: 7638627
    [No Abstract]   [Full Text] [Related]  

  • 16. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of radiation therapy after local excision of invasive and noninvasive breast cancer.
    Marks LB; Prosnitz LR
    Surg Oncol Clin N Am; 1997 Apr; 6(2):359-79. PubMed ID: 9115501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J
    Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
    Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
    Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.
    Veronesi P; Gentilini O; Fernandez JR; Magnoni F
    Breast; 2009 Oct; 18 Suppl 3():S90-2. PubMed ID: 19914551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.